RESTASIS ( DrugBank: - )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
53	シェーグレン症候群	1
162	類天疱瘡（後天性表皮水疱症を含む。）	1

53. シェーグレン症候群

---

臨床試験数 : 283 /  薬物数 : 320 - (DrugBank : 101) / 標的遺伝子数 : 56 - 標的パスウェイ数 : 181

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02004067 (ClinicalTrials.gov)	January 2013	3/12/2013	Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease	Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease	Primary Sjogren Syndrome;Secondary Sjogren Syndrome;Aqueous Deficient Dry Eye Disease;Evaporative Dry Eye Disease	Drug: Restasis;Drug: Refresh Endura	Federal University of São Paulo	Allergan	Completed	18 Years	65 Years	All	100	Phase 4	Brazil

162. 類天疱瘡（後天性表皮水疱症を含む。）

---

臨床試験数 : 83 /  薬物数 : 128 - (DrugBank : 51) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 142

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-000480-41-IT (EUCTR)	27/05/2008	10/06/2008	Multicenter, randomised, double masked, controlled clinical trial on the safety and efficacy of Cyclosporine A eyedrop treatment on patients with ocular cicatricial pemphigoid. - ND	Multicenter, randomised, double masked, controlled clinical trial on the safety and efficacy of Cyclosporine A eyedrop treatment on patients with ocular cicatricial pemphigoid. - ND	Ocular cicatricial pemphigoid (OCP) MedDRA version: 9.1;Level: LLT;Classification code 10010746;Term: Conjunctivitis chronic	Trade Name: RESTASIS INN or Proposed INN: Cyclosporine	UNIVERSITA' CAMPUS BIOMEDICO	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Italy